Artelo Biosciences to Showcase ART26.12 at IASP 2026 Congress
Artelo Biosciences says it will showcase its first-in-human FABP5 inhibitor ART26.12 at the IASP 2026 World Congress on Pain.
Artelo Biosciences says it will showcase its first-in-human FABP5 inhibitor ART26.12 at the IASP 2026 World Congress on Pain.